Mean platelet volume associated with aortic distensibility, chronic inflammation, and diabetes in patients with stable coronary artery disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 4, 2014, Pages 416-421

  Şahin, Durmuş Yildiray ^a   Gür, Mustafa ^a   Elbasan, Zafer ^a   Yildirim, Arafat ^a   Akilli, Rabia Eker ^a   Koyunsever, Nermin Yildiz ^a   Özaltun, Betül ^a   Gözübüyük, Gökhan ^a   Kivrak, Ali ^a   Çayli, Murat ^a  

^a ADANA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

blood platelets; C reactive protein; coronary artery disease; platelet count; vascular stiffness

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AORTA ELASTICITY; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYNTAX SCORE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; ANGIOCARDIOGRAPHY; AORTA; BLOOD; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY; INFLAMMATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; THROMBOCYTE;

AORTA; BLOOD FLOW VELOCITY; BLOOD PLATELETS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFLAMMATION; MALE; MEAN PLATELET VOLUME; MIDDLE AGED;

EID: 84898973206     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612468941     Document Type: Article

References (44)

1. Frossard M, Fuchs I, Leitner JM, et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation. 2004 ; 110 (11). 1392-1397
2. Bancroft AJ, Abel EW, Mclaren M, Belch JJ. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2000 ; 11 (7). 379-387
3. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991 ; 338 (8780). 1409-1411
4. Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002 ; 117 (2). 399-404
5. Lancé MD, Sloep M, Henskens YM, Marcus MA. Mean platelet volume as a diagnostic marker for cardiovascular disease: drawbacks of preanalytical conditions and measuring techniques. Clin Appl Thromb Hemost. 2012 ; 18 (6). 561-568
6. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999 ; 281 (7). 634-639
7. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001 ; 103 (9). 1245-1249
8. Mitchell GF, Moyé LA, Braunwald E, et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation. 1997 ; 96 (12). 4254-4260
9. Vaccarino V, Berger A, Abramson J, et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol. 2001 ; 88 (9). 980-986
10. Kostis J, Lawrence-Nelson J, Ranjan R, Wilson A, Kostis W, Lacy C. Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group. Am J Hypertens. 2001 ; 14 (8 pt 1). 798-803
11. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997 ; 30 (6). 1410-1415
12. Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004 ; 90 (1). 37-43
13. Yildiz A, Gur M, Yilmaz R, Demirbag R. The association of elasticity indexes of ascending aorta and the presence and the severity of coronary artery disease. Coron Artery Dis. 2008 ; 19 (5). 311-317
14. Malayeri AA, Natori S, Bahrami H, et al. Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from theMulti-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2008 ; 102 (4). 491-496
15. Wang RT, Li Y, Zhu XY, Zhang YN. Increased mean platelet volume is associated with arterial stiffness. Platelets. 2011 ; 22 (6). 447-451
16. Tavil Y, Sen N, Yazici H, et al. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. Platelets. 2010 ; 21 (5). 368-372
17. Murat SN, Duran M, Kalay N, et al. Relation between mean platelet volume and severity of atherosclerosis in patients with acute coronary syndromes [published online February 14, 2012]. Angiology. :
18. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989 ; 2 (5). 358-367
19. Stefanadis C, Dernellis J, Vlachopoulos C, et al. Aortic function in arterial hypertension determined by pressure-diameter relation: effects of diltiazem. Circulation. 1997 ; 96 (6). 1853-1858
20. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 ; 1 (2). 219-227
21. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des. 2011 ; 17 (1). 47-58
22. Bilen E, Tanboga IH, Kurt M, et al. Mean platelet volume is increased in patients with bicuspid aortic valve. Clin Appl Thromb Hemost. 2012 ; 18 (4). 351-355
23. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009 ; 63 (10). 1509-1515
24. Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009 ; 102 (2). 248-257
25. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006 ; 147 (suppl 1). S193 - S201
26. Bellien J, Favre J, Iacob M, et al. Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor duringchanges in blood flow in humans. Hypertension. 2010 ; 55 (3). 674-680
27. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002 ; 90 (3). 251-262
28. Chung AW, Yang HH, Kim JM, et al. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation. 2009 ; 120 (9). 792-801
29. Yamasaki F, Furuno T, Sato K, et al. Association between arterial stiffness and platelet activation. J Hum Hypertens. 2005 ; 19 (7). 527-533
30. Al-Mallah MH, Nasir K, Katz R, et al. Thoracic aortic distensibility and thoracic aortic calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2010 ; 106 (4). 575-580
31. Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, Lowe GDO. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost. 2009 ; 7 (10). 1605-1611
32. Shah T, Casas JP, Cooper JA, et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol. 2008 ; 38 (1). 217-231
33. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105 (9). 1135-1143
34. Danesh J, Wheeler JG, Hirshfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350 (14). 1387-1397
35. Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008 ; 5 (4). e78
36. Kaya MG, Yarlioglues M, Gunebakmaz O, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis. 2010 ; 209 (1). 278-282
37. Papanas N, Symeonidis G, Maltezos E, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004 ; 15 (8). 475-478
38. Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol. 2003 ; 92 (11). 1362-1365
39. De Luca G, Santagostino M, Secco GG, et al. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009 ; 206 (1). 292-297
40. Glud T, Schmidt EB, Kristensen SD, Arnfred T. Platelet number and volume during myocardial infarction in relation to infarct size. Acta Med Scand. 1986 ; 220 (5). 401-405
41. Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 1988 ; 72 (1). 1-8
42. Buttarello M, Plebani M. Automated blood cell counts: state of the art. Am J Clin Pathol. 2008 ; 130 (1). 104-116
43. Jackson SR, Carter JM. Platelet volume: laboratory measurement and clinical application. Blood Rev. 1993 ; 7 (2). 104-113
44. Threatte GA. Usefulness of the mean platelet volume. Clin Lab Med. 1993 ; 13 (4). 937-950